Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient

NCT07223632 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Charcot Marie Tooth Disease (CMT)
Neuromuscular Diseases (NMD)

Interventions

DRUG: VCA-894A

Sponsor

Vanda Pharmaceuticals